Nigeria has approved a new malaria vaccine developed by scientists at Oxford University, following Ghana’s recent approval.
The head of Nigeria’s National Agency for Food and Drugs Administration, Mojisola Adeyeye, said the vaccine, known as R21, would be used for the prevention of malaria in children aged between five months and three years – the most vulnerable group.
The approval is unique as it comes before the publication of final stage trial data, but it is believed to be 80% effective. Nigeria has the highest number of malaria deaths worldwide, with over 6,000 deaths annually, mostly affecting children in Sub-Saharan Africa.
An Oxford University malaria vaccine has been approved for use in Ghana. It is the first time the shot has received regulatory approval anywhere in the world. Ghana’s Food and … Read more »
(file photo).
